[go: up one dir, main page]

DK0696577T3 - Syntetiske excitatoriske aminosyrer - Google Patents

Syntetiske excitatoriske aminosyrer

Info

Publication number
DK0696577T3
DK0696577T3 DK95305632T DK95305632T DK0696577T3 DK 0696577 T3 DK0696577 T3 DK 0696577T3 DK 95305632 T DK95305632 T DK 95305632T DK 95305632 T DK95305632 T DK 95305632T DK 0696577 T3 DK0696577 T3 DK 0696577T3
Authority
DK
Denmark
Prior art keywords
amino acids
excitatory amino
synthetic excitatory
synthetic
acids
Prior art date
Application number
DK95305632T
Other languages
Danish (da)
English (en)
Inventor
James Allen Monn
David R Helton
Darryle D Schoepp
Joseph P Tizzano
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/496,643 external-priority patent/US5750566A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0696577T3 publication Critical patent/DK0696577T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30Unsaturated compounds
    • C07C62/38Unsaturated compounds containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/18All rings being cycloaliphatic the ring system containing six carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK95305632T 1994-08-12 1995-08-11 Syntetiske excitatoriske aminosyrer DK0696577T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28995794A 1994-08-12 1994-08-12
US33734994A 1994-11-10 1994-11-10
US08/496,643 US5750566A (en) 1994-08-12 1995-06-29 Synthetic excitatory amino acids

Publications (1)

Publication Number Publication Date
DK0696577T3 true DK0696577T3 (da) 1999-06-23

Family

ID=27403949

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95305632T DK0696577T3 (da) 1994-08-12 1995-08-11 Syntetiske excitatoriske aminosyrer

Country Status (24)

Country Link
US (2) US5925782A (fr)
EP (1) EP0696577B1 (fr)
JP (1) JP2883297B2 (fr)
CN (1) CN1066135C (fr)
AP (1) AP758A (fr)
AT (1) ATE172186T1 (fr)
AU (2) AU3325195A (fr)
BG (1) BG62728B1 (fr)
CA (1) CA2156024C (fr)
CZ (1) CZ291270B6 (fr)
DE (1) DE69505318T2 (fr)
DK (1) DK0696577T3 (fr)
ES (1) ES2122456T3 (fr)
FI (1) FI114861B (fr)
HU (1) HU223845B1 (fr)
IL (2) IL114910A (fr)
MY (1) MY115977A (fr)
NO (1) NO306342B1 (fr)
NZ (1) NZ272772A (fr)
PL (1) PL182285B1 (fr)
RO (1) RO119147B1 (fr)
SK (1) SK281288B6 (fr)
TW (1) TW438741B (fr)
WO (1) WO1996005175A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118727A (en) * 1995-06-29 2003-01-12 Lilly Co Eli (-)-2-spiro-5-hydantoinbicyclo [3.1.0] hexane-6-carboxylic acid, salts thereof and use thereof for the preparation of (+)-(2) aminobicyclo [3.1.0] hexane-2,6-dicarboxylic acid
TR199800877T2 (xx) * 1995-11-16 1998-09-21 Eli Lilly And Company Uyar�c� amino asit t�revleri.
BR9611521A (pt) 1995-11-16 1999-06-29 Lilly Co Eli Antagonistas de receptor de aminoácido excitador
GB9605429D0 (en) * 1995-11-16 1996-05-15 Lilly Co Eli Excitatory amino acid receptor antagonists
US5688826A (en) * 1995-11-16 1997-11-18 Eli Lilly And Company Excitatory amino acid derivatives
US5912248A (en) * 1995-11-16 1999-06-15 Eli Lilly And Company Excitatory amino acid receptor antagonists
ZA969485B (en) * 1995-11-16 1998-05-12 Lilly Co Eli Excitatory amino acid receptor antagonists.
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US5824662A (en) * 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
CN1230889A (zh) 1996-09-27 1999-10-06 吉尔福特药业有限公司 NAALADase组合物和治疗谷氨酸异常及在动物中产生神经元活性的方法
AU6248798A (en) * 1997-01-29 1998-08-18 Eli Lilly And Company Treatment for premenstrual dysphoric disorder
ZA983930B (en) * 1997-05-14 1999-11-08 Lilly Co Eli Excitatory amino acid receptor modulators.
US6825211B1 (en) 1997-07-18 2004-11-30 Georgetown University Bicyclic metabotropic glutamate receptor ligands
PT891978E (pt) * 1997-07-18 2002-07-31 Hoffmann La Roche Derivados de 5h-tiazolo (3,2-a) pirimidina
WO1999003822A1 (fr) * 1997-07-18 1999-01-28 Georgetown University Ligands des recepteurs bicycliques metabotropiques du glutamate
JP3727791B2 (ja) * 1998-01-08 2005-12-14 ファイザー・プロダクツ・インク 二環式[3.1.0]ヘキサン及び関連化合物
AU734812B2 (en) 1998-01-28 2001-06-21 Taisho Pharmaceutical Co., Ltd. Fluorine-containing amino acid derivatives
US5933378A (en) * 1998-02-26 1999-08-03 Micron Technology, Inc. Integrated circuit having forced substrate test mode with improved substrate isolation
EP1396273A1 (fr) * 1998-03-17 2004-03-10 Pfizer Products Inc. Bicyclo(2.2.1.)heptanes et composés associés
KR100372981B1 (ko) * 1998-03-17 2003-02-25 화이자 프로덕츠 인크. 비시클로[2.2.1]헵탄 및 관련 화합물
GB9815542D0 (en) * 1998-07-17 1998-09-16 Lilly Co Eli Bicyclohexane derivatives
KR100469182B1 (ko) 1998-08-31 2005-02-02 다이쇼 세이야꾸 가부시끼가이샤 6-플루오로비시클로[3.1.0]헥산 유도체
CH694053A5 (de) * 1998-09-03 2004-06-30 Hoffmann La Roche Verfahren zur Herstellung von 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarbonsäure-Derivaten.
JP4192331B2 (ja) 1999-04-16 2008-12-10 住友化学株式会社 光学活性2−オキソビシクロ[3.1.0]ヘキサン−6−カルボン酸誘導体の製造方法
JP4783967B2 (ja) * 1999-07-21 2011-09-28 大正製薬株式会社 含フッ素アミノ酸誘導体を有効成分とする医薬
GB2355982A (en) * 1999-11-03 2001-05-09 Lilly Co Eli Heterocyclic amino acids
US7256217B2 (en) * 2001-01-11 2007-08-14 Eli Lilly And Company Prodrugs of excitatory amino acids
EP1310480A1 (fr) * 2001-11-07 2003-05-14 Eli Lilly & Company Prodrugs d'aminoacides excitants
WO2002055485A1 (fr) 2001-01-11 2002-07-18 Eli Lilly And Company Promedicaments d'acides amines excitateurs
WO2003045898A1 (fr) * 2001-11-23 2003-06-05 Eli Lilly And Company Promedicaments d'acides amines excitateurs
US7456221B2 (en) 2001-12-21 2008-11-25 Eli Lilly And Company Prodrugs of excitatory amino acids
AU2002361611A1 (en) * 2001-12-21 2003-07-24 Eli Lilly And Company Prodrugs of excitatory amino acids
US20040116489A1 (en) * 2002-02-12 2004-06-17 Massey Steven Marc Synthetic excitatory amino acids
CA2580730C (fr) * 2003-09-25 2015-01-13 Cenomed, Inc. Derives de tetrahydroindolone destines au traitement d'etats neurologiques
US20050107439A1 (en) * 2003-11-10 2005-05-19 Helton David R. Composition and method for treating emesis
EP2219648A4 (fr) * 2007-11-09 2010-11-03 Cenomed Biosciences Llc Traitement des troubles du stress post-traumatique avec des composés de tétrahydroindolone et d'arylpipérazine
US20090264443A1 (en) * 2008-04-18 2009-10-22 David Helton Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
WO2010111080A2 (fr) 2009-03-27 2010-09-30 Eli Lilly And Company Traitement optimisé de la schizophrénie

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3704312A (en) * 1970-10-30 1972-11-28 American Home Prod Bialicyclic amino acids
US3746495A (en) * 1971-06-01 1973-07-17 American Home Prod Anti-ulcer therapy
JP2757960B2 (ja) 1988-10-17 1998-05-25 サントリー株式会社 (2R,3S,4S)−α−(カルボキシシクロプロピル)グリシン
EP0564658B1 (fr) 1991-10-18 1996-04-24 Suntory Limited 2-(2,3-dicarboxycyclopropyl)glycine et son procede de production
GB9325368D0 (en) * 1993-12-10 1994-02-16 Univ Bristol Organic compounds
US5750566A (en) * 1994-08-12 1998-05-12 Eli Lilly And Company Synthetic excitatory amino acids
IL118727A (en) 1995-06-29 2003-01-12 Lilly Co Eli (-)-2-spiro-5-hydantoinbicyclo [3.1.0] hexane-6-carboxylic acid, salts thereof and use thereof for the preparation of (+)-(2) aminobicyclo [3.1.0] hexane-2,6-dicarboxylic acid
US5688826A (en) 1995-11-16 1997-11-18 Eli Lilly And Company Excitatory amino acid derivatives

Also Published As

Publication number Publication date
EP0696577B1 (fr) 1998-10-14
NO306342B1 (no) 1999-10-25
HU223845B1 (hu) 2005-02-28
IL114910A0 (en) 1995-12-08
NZ272772A (en) 1997-10-24
HK1013983A1 (en) 1999-09-17
BG101213A (en) 1998-03-31
NO953191D0 (no) 1995-08-14
PL182285B1 (pl) 2001-12-31
CA2156024A1 (fr) 1996-02-13
AU3325195A (en) 1996-03-07
MY115977A (en) 2003-10-31
EP0696577A1 (fr) 1996-02-14
DE69505318D1 (de) 1998-11-19
CZ207495A3 (en) 1996-05-15
WO1996005175A1 (fr) 1996-02-22
AP758A (en) 1999-09-10
CN1066135C (zh) 2001-05-23
HU9502380D0 (en) 1996-05-28
ES2122456T3 (es) 1998-12-16
FI114861B (fi) 2005-01-14
SK13397A3 (en) 1997-07-09
JP2883297B2 (ja) 1999-04-19
US5925782A (en) 1999-07-20
PL309972A1 (en) 1996-02-19
CA2156024C (fr) 2004-10-05
SK281288B6 (sk) 2001-02-12
IL133493A0 (en) 2001-04-30
RO119147B1 (ro) 2004-04-30
CZ291270B6 (cs) 2003-01-15
IL114910A (en) 2000-06-29
CN1123272A (zh) 1996-05-29
JPH08188561A (ja) 1996-07-23
AU692276B2 (en) 1998-06-04
ATE172186T1 (de) 1998-10-15
BG62728B1 (bg) 2000-06-30
AU2853095A (en) 1996-02-22
HUT75524A (en) 1997-05-28
FI953837A0 (fi) 1995-08-14
NO953191L (no) 1996-02-13
US5925680A (en) 1999-07-20
DE69505318T2 (de) 1999-03-25
AP9700922A0 (en) 1997-01-31
FI953837L (fi) 1996-02-13
TW438741B (en) 2001-06-07

Similar Documents

Publication Publication Date Title
DK0696577T3 (da) Syntetiske excitatoriske aminosyrer
FI965005A7 (fi) Synteettiset johtajapeptidisekvensit
FI961350L (fi) Hapteenimerkityt peptidit
FI965225A7 (fi) Uusia peptidejä
ATE238984T1 (de) Sulfonylaminocarbonsäuren
NO993901L (no) Bisykliske aminosyrer
FI964318L (fi) Uusia kinoloni-5-(N-heterosubstituoitu amino)-antimikrobisia aineita
DE69635886D1 (de) Exzitatorisch wirkende Aminosäurederivate
BR9610239A (pt) Proteínas de fusão-alérgeno-xcd32
FI970168A0 (fi) Peptidejä
BR9609671A (pt) Amino uracilas substituídas
FI964363L (fi) Peptidejä
DK1043332T3 (da) Dipeptider indeholdende cyclopentan-beta-aminosyrer
SK2694U (sk) Aminokyselinové nukleové kyseliny
TR199701666A3 (tr) Sismanliga karsi proteinler
BR9606756A (pt) Peptídeo
FI963568L (fi) Peptidijohdannaisia
NO981052D0 (no) Peptidderivater
NO981051D0 (no) Peptidderivater
ZA956773B (en) Synthetic excitatory amino acids.
SI0696577T1 (en) Synthetic excitatory amino acids
BR1100812A (pt) Peptìdeo
SE9504467D0 (sv) Peptide
FI954924A0 (fi) Syntetiska smoerjmedelsbasoljor